National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

This is VAERS ID 270076

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 12/31/2007

VAERS ID: 270076
VAERS Form:
Age:65.0
Sex:Female
Location:Unknown
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. - / - UN / -

Administered by: Other      Purchased by: Unknown
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type':

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19"-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


Changed on 12/8/2009

VAERS ID: 270076 Before After
VAERS Form:
Age:65.0
Sex:Female
Location:Unknown
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. - / - UN / -

Administered by: Other      Purchased by: Unknown Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': (blank) WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19"-Dec-2006, 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


Changed on 1/5/2010

VAERS ID: 270076 Before After
VAERS Form:
Age:65.0
Sex:Female
Location:Unknown
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. - / - UN / -

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0 (blank)     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


Changed on 6/14/2014

VAERS ID: 270076 Before After
VAERS Form:
Age:65.0
Sex:Female
Location:Unknown
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. - / - UN / -

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


Changed on 5/14/2017

VAERS ID: 270076 Before After
VAERS Form:
Age:65.0
Sex:Female
Location:Unknown
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. - / - UN / -

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


Changed on 9/14/2017

VAERS ID: 270076 Before After
VAERS Form:(blank) 1
Age:65.0
Sex:Female
Location:Unknown
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. - / - UNK UN / -

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


Changed on 2/14/2018

VAERS ID: 270076 Before After
VAERS Form:1
Age:65.0
Sex:Female
Location:Unknown
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


Changed on 6/14/2018

VAERS ID: 270076 Before After
VAERS Form:1
Age:65.0
Sex:Female
Location:Unknown
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


Changed on 8/14/2018

VAERS ID: 270076 Before After
VAERS Form:1
Age:65.0
Sex:Female
Location:Unknown
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


Changed on 9/14/2018

VAERS ID: 270076 Before After
VAERS Form:1
Age:65.0
Sex:Female
Location:Unknown
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


Changed on 10/14/2018

VAERS ID: 270076 Before After
VAERS Form:1
Age:65.0
Sex:Female
Location:Unknown
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


Changed on 8/14/2019

VAERS ID: 270076 Before After
VAERS Form:1
Age:65.0
Sex:Female
Location:Unknown
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (ZOSTAVAX) ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


Changed on 12/10/2020

VAERS ID: 270076 Before After
VAERS Form:1
Age:65.0
Sex:Female
Location:Unknown Wisconsin
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


Changed on 12/24/2020

VAERS ID: 270076 Before After
VAERS Form:1
Age:65.0
Sex:Female
Location:Wisconsin
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


Changed on 12/30/2020

VAERS ID: 270076 Before After
VAERS Form:1
Age:65.0
Sex:Female
Location:Wisconsin
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


Changed on 5/7/2021

VAERS ID: 270076 Before After
VAERS Form:1
Age:65.0
Sex:Female
Location:Wisconsin
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


Changed on 5/21/2021

VAERS ID: 270076 Before After
VAERS Form:1
Age:65.0
Sex:Female
Location:Wisconsin
Vaccinated:2006-12-19
Onset:2006-12-19
Submitted:2007-01-04
Entered:2007-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=270076&WAYBACKHISTORY=ON


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166